Barclays
EIGR

Barclays’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-21,271
Closed -$19K 4497
2023
Q1
$19K Sell
21,271
-1,594,176
-99% -$1.42M ﹤0.01% 4006
2022
Q4
$1.91M Buy
1,615,447
+1,088,680
+207% +$1.29M ﹤0.01% 1669
2022
Q3
$3.97M Sell
526,767
-289
-0.1% -$2.18K ﹤0.01% 1230
2022
Q2
$3.32M Buy
527,056
+21,859
+4% +$138K ﹤0.01% 1297
2022
Q1
$4.19M Buy
505,197
+466,339
+1,200% +$3.87M ﹤0.01% 1272
2021
Q4
$202K Buy
38,858
+25,769
+197% +$134K ﹤0.01% 2827
2021
Q3
$87K Buy
13,089
+4,782
+58% +$31.8K ﹤0.01% 3269
2021
Q2
$70K Sell
8,307
-18,259
-69% -$154K ﹤0.01% 3257
2021
Q1
$235K Sell
26,566
-39,558
-60% -$350K ﹤0.01% 3061
2020
Q4
$814K Sell
66,124
-20,411
-24% -$251K ﹤0.01% 2084
2020
Q3
$704K Buy
86,535
+31,572
+57% +$257K ﹤0.01% 2121
2020
Q2
$527K Buy
54,963
+37,079
+207% +$356K ﹤0.01% 2300
2020
Q1
$123K Sell
17,884
-7,336
-29% -$50.5K ﹤0.01% 2740
2019
Q4
$375K Buy
25,220
+11,286
+81% +$168K ﹤0.01% 2853
2019
Q3
$142K Sell
13,934
-3,672
-21% -$37.4K ﹤0.01% 3213
2019
Q2
$187K Sell
17,606
-55,091
-76% -$585K ﹤0.01% 3240
2019
Q1
$1.02M Sell
72,697
-13,949
-16% -$195K ﹤0.01% 2138
2018
Q4
$881K Buy
86,646
+86,642
+2,166,050% +$881K ﹤0.01% 1902
2018
Q3
$0 Hold
4
﹤0.01% 4519
2018
Q2
$0 Hold
4
﹤0.01% 4442
2018
Q1
$0 Sell
4
-5,600
-100% ﹤0.01% 4436
2017
Q4
$78K Buy
5,604
+5,600
+140,000% +$77.9K ﹤0.01% 3126
2017
Q3
$0 Sell
4
-7,100
-100% ﹤0.01% 4175
2017
Q2
$56K Buy
7,104
+6,477
+1,033% +$51.1K ﹤0.01% 2976
2017
Q1
$7K Buy
627
+623
+15,575% +$6.96K ﹤0.01% 3602
2016
Q4
$0 Sell
4
-26
-87% ﹤0.01% 4035
2016
Q3
$0 Buy
30
+26
+650% ﹤0.01% 4097
2016
Q2
$0 Hold
4
﹤0.01% 3916
2016
Q1
$0 Sell
4
-68
-94% ﹤0.01% 3726
2015
Q4
$0 Sell
72
-11,108
-99% ﹤0.01% 3850
2015
Q3
$11K Buy
11,180
+11,108
+15,428% +$10.9K ﹤0.01% 3046
2015
Q2
$0 Sell
72
-98,501
-100% ﹤0.01% 4239
2015
Q1
$1.77M Buy
98,573
+98,473
+98,473% +$1.77M ﹤0.01% 1328
2014
Q4
$2K Sell
100
-907
-90% -$18.1K ﹤0.01% 4036
2014
Q3
$10K Sell
1,007
-6,557
-87% -$65.1K ﹤0.01% 3738
2014
Q2
$121K Buy
7,564
+7,391
+4,272% +$118K ﹤0.01% 2642
2014
Q1
$2K Buy
+173
New +$2K ﹤0.01% 4156